Leeds research could revolutionise vaccine development

Research which has identified a way of making a safer and cheaper polio vaccine is to be scaled-up – to see if it could be used in commercial vaccine production. The new approach, which has the potential to revolutionise vaccine development across the board, is the result of a scientific collaboration led by the University. It is based on a process using harmless proteins called virus-like particles (VLPs) rather than a live virus, which carries the risk of escaping and infecting people.

Read the full press release on the University of Leeds website